ImmunityBio, Inc. Common Stock
€6.797
EUR
Last updated on --.
24h volume111.80K
24h highest6.8193 EUR
24h lowest6.7042 EUR
24h Price movement-0.13%
IBRX recent prices
24 Hours
-0.13%-€0.008594
30 days
+8.50%+€0.53283
60 days
-2.03%-€0.12891
90 days
-17.17%-€1.410
Key data
Previous close6.8064 EUR
Market cap7.25B EUR
Volume111.80K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.70471 EUR
Net income (FY)-734.45M EUR
Revenue (FY)121.16M EUR
Last report date7 May 2026
About ImmunityBio, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)691.00
Revenue per employee (FY)175.33K EUR
Net income per employee (FY)-1.06M EUR
Listed onNasdaq
IBRX conversion tables
 |  |
|---|---|
| 0.5 IBRX | 3.398 EUR |
| 1 IBRX | 6.797 EUR |
| 5 IBRX | 33.98 EUR |
| 10 IBRX | 67.97 EUR |
| |
|---|---|
| 0.5 EUR | 0.073553 IBRX |
| 1 EUR | 0.14711 IBRX |
| 5 EUR | 0.73553 IBRX |
| 10 EUR | 1.471 IBRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IBRX is trading at €6.797, -0.13% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IBRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IBRX is currently trading at €6.797, -0.13% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IBRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IBRX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IBRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IBRX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
ImmunityBio, Inc. Common Stock's market cap is currently 7.25B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume111.80K
24h highest6.8193 EUR
24h lowest6.7042 EUR
24h Price movement-0.13%
Start trade with IBRX Perpetual
Sign up to trade